ganirelix [3610]



ganirelix


SMILES CCNC(=NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN=C(NCC)NCC)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc1cccnc1)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCCC1C(=O)N[C@H](C)C(N)=O)NCC
InChIKey GJNXBNATEDXMAK-RXXWGPEVSA-N
Sequence AFASYXLXPA
HELM PEPTIDE1{[ac].[*C(=O)C(Cc1ccc2ccccc2c1)N* |$_R2;;;;;;;;;;;;;;;;_R1$|].[*C(=O)[C@H](Cc1ccc(cc1)Cl)N* |$_R2;;;;;;;;;;;;;_R1$|].[*C(=O)[C@H](Cc1cccnc1)N* |$_R2;;;;;;;;;;;;_R1$|].[dS].[dY].[*C(=O)[C@@H](CCCCN=C(NCC)NCC)N* |$_R2;;;;;;;;;;;;;;;;;_R1$|].L.[*C(=O)[C@H](CCCCN=C(NCC)NCC)N* |$_R2;;;;;;;;;;;;;;;;;_R1$|].(P,[dP]).[dA].[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 16
Hydrogen bond donors 16
Rotatable bonds 44
Log P 2.273
Molecular weight (Da) 1568.8
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

ganirelix


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.